The Journal of Thoracic and Cardiovascular Surgery
Volume 128, Issue 4 , Pages 552-561 , October 2004

Clinical pulmonary autograft valves: Pathologic evidence of adaptive remodeling in the aortic site

  • Elena Rabkin-Aikawa, MD, PhD

      Affiliations

    • Department of Pathology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
  • ,
  • Masanori Aikawa, MD, PhD

      Affiliations

    • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
  • ,
  • Mark Farber, MS

      Affiliations

    • Department of Pathology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
  • ,
  • Johannes R. Kratz, MS

      Affiliations

    • Department of Pathology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
  • ,
  • Guillermo Garcia-Cardena, PhD

      Affiliations

    • Department of Pathology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
  • ,
  • Nicholas T. Kouchoukos, MD

      Affiliations

    • Cardiac, Thoracic and Vascular Surgery, Inc, St Louis, Mo, USA
  • ,
  • Max B. Mitchell, MD

      Affiliations

    • Cardiac Surgery Department, The Children's Hospital, University of Colorado Health Sciences Center, Denver, Colo, USA
  • ,
  • Richard A. Jonas, MD

      Affiliations

    • Department of Cardiovascular Surgery, Children's Hospital, Harvard Medical School, Boston, Mass, USA
  • ,
  • Frederick J. Schoen, MD, PhD

      Affiliations

    • Department of Pathology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA
    • Harvard-MIT Division of Health Sciences and Technology (HST), Harvard Medical School, Boston, Mass, USA
    • Corresponding Author InformationAddress for reprints: Frederick J. Schoen, MD, PhD, Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA

Received 20 November 2003 ,Revised 22 March 2004 ,Accepted 19 April 2004.

References 

  1. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet. 1967;2:956–958
  2. Elkins RC, Knott-Graig CJ, Kent EW, et al.  Pulmonary autograft in children (realized growth potential). Ann Thorac Surg. 1994;57:1387–1394
  3. Kouchoukos NT, Davila-Roman VG, Spray TL, et al.  Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease. N Engl J Med. 1994;330:1–6
  4. Chambers J, Somerville J, Stone S, et al.  Pulmonary autograft procedure for aortic valve disease. Circulation. 1997;96:2206–2214
  5. Aikawa M, Rabkin E, Okada Y, et al.  Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma (a potential mechanism of lesion stabilization). Circulation. 1998;97:2433–2444
  6. Rabkin E, Aikawa M, Stone JR, et al.  Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104:2525–2532
  7. Schurch W, Seemayer TA, Gabbiani G. The myofibroblast (a quarter century after its discovery). Am J Surg Pathol. 1998;22:141–147
  8. Shin D, Garcia-Cardena G, Shin-Ichiro H, et al.  Expression of EphrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol. 2001;230:139–150
  9. Sukhova GK, Schoenbeck U, Rabkin E, et al.  Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999;99:2503–2509
  10. Schoen FJ. Aortic valve structure-function correlations (role of elastic fibers no longer a stretch of the imagination). J Heart Valve Dis. 1997;6:1–6
  11. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves (comparison with aortic valves from ortotopic heart transplants). J Thorac Cardiovasc Surg. 1998;115:118–127
  12. Schoen FJ. Future directions in tissue heart valves (impact of recent insights from biology and pathology). J Heart Valve Dis. 1999;8:350–358
  13. Schoen FJ, Levy RJ. Tissue heart valves (current challenges and future research perspectives). J Biomed Mater Res. 1999;47:439–465
  14. Weston MW, Yoganathan AP. Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Ann Biomed Eng. 2001;29:752–763
  15. Tamura K, Jones M, Yamada I, et al.  Wound healing in the mitral valve. J Heart Valve Dis. 2000;9:53–63
  16. Rabkin E, Hoerstrup SP, Aikawa M, et al.  Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in vitro culture and in vivo remodeling. J Heart Valve Dis. 2002;11:308–314
  17. Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res. 2002;91:877–887
  18. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases (structure, function and biochemistry). Circ Res. 2003;92:827–839
  19. Mao D, Lee JK, VanVickle SJ, Thompson RW. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurisms and vascular smooth muscle cells in culture. Biochem Biophys Res Commun. 1999;261:904–910
  20. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702–712
  21. de Sa M, Moshkovitz Y, Butany J, et al.  Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease (clinical relevance to the Ross procedure). J Thorac Cardiovasc Surg. 1999;118:588–594
  22. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, Maurer G, Baumgartner H, Lang IM. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation. 1999;99:2138–2143
  23. Fedak PWM, de Sa MPL, Verma S, et al.  Vascular matrix remodeling in patients with bicuspid aortic valve malformations (implications for aortic dilatation). J Thorac Cardiovasc Surg. 2003;126:797–806
  24. Schmidt FK, Hilker M, Kampman C, et al.  Clinical performance of native pulmonary valve in the systemic circulation. J Heart Valve Dis. 1988;7:620–625
  25. Solymar L, Sudow G, Holmgren D. Increase in size of the pulmonary autograft after the Ross operation in children (growth or dilation?). J Thorac Cardiovasc Surg. 2000;119:4–9
  26. Sievers HH, Leyh R, Loose R, et al.  Time course dimension and function of the autograft pulmonary root in the aortic position. J Thorac Cardiovasc Surg. 1993;105:775–780
  27. Hokken RB, Bogers AJJC, Taams MA, et al.  Does the pulmonary autograft in the aortic position in adults increase in diameter? An echocardiographic study. J Thorac Cardiovasc Surg. 1997;113:667–674
  28. David TE, Omran A, Ivanov J, et al.  Dilation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg. 2000;119:210–220
  29. Luciani GB, Casali G, Favaro A, et al.  Fate of the aortic root late after Ross operation. Circulation. 2003;108(suppl II):II61, 67

 Supported in part by National Heart, Lung, and Blood Institute grant PO1 HL-48743 (to Dr Peter Libby).

PII: S0022-5223(04)00641-5

doi: 10.1016/j.jtcvs.2004.04.016

The Journal of Thoracic and Cardiovascular Surgery
Volume 128, Issue 4 , Pages 552-561 , October 2004